Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: As late-stage biotech pipelines mature, fair-value remeasurements under U.S. Generally Accepted Accounting Principles (GAAP) are emerging as critical indicators of tangible scienti
(Financial Post, 2025-11-20T13:34:31Z)